2. Makarawate P, Glinge C, Khongphatthanayothin A, Walsh R, Mauleekoonphairoj J, Amnueypol M,
et al. Common and rare susceptibility genetic variants predisposing to Brugada syndrome in Thailand. Heart Rhythm 2020;17:2145–2153.
3. Makarawate P, Chaosuwannakit N, Ruamcharoen Y, Panthongviriyakul A, Pongchaiyakul C, Tharaksa P,
et al. Prevalence and associated factors of early repolarization pattern in healthy young northeastern Thai men: a correlation study with Brugada electrocardiography. J Arrhythm 2015;31:215–220.
4. Vutthikraivit W, Rattanawong P, Putthapiban P, Sukhumthammarat W, Vathesatogkit P, Ngarmukos T,
et al. Worldwide prevalence of Brugada syndrome: a systematic review and meta-analysis. Acta Cardiol Sin 2018;34:267–277.
5. Barc J, Tadros R, Glinge C, Chiang DY, Jouni M, Simonet F,
et al. Genome-wide association analyses identify new Brugada syndrome risk loci and highlight a new mechanism of sodium channel regulation in disease susceptibility. Nat Genet 2022;54:232–239.
6. Le Scouarnec S, Karakachoff M, Gourraud JB, Lindenbaum P, Bonnaud S, Portero V,
et al. Testing the burden of rare variation in arrhythmia-susceptibility genes provides new insights into molecular diagnosis for Brugada syndrome. Hum Mol Genet 2015;24:2757–2763.
10. Telenti A, Pierce LC, Biggs WH, di Iulio J, Wong EH, Fabani MM,
et al. Deep sequencing of 10,000 human genomes. Proc Natl Acad Sci U S A 2016;113:11901–11906.
12. Moustafa A, Xie C, Kirkness E, Biggs W, Wong E, Turpaz Y,
et al. The blood DNA virome in 8,000 humans. PLoS Pathog 2017;13:e1006292.
15. Kremer D, Gruchot J, Weyers V, Oldemeier L, Gottle P, Healy L,
et al. pHERV-W envelope protein fuels microglial cell-dependent damage of myelinated axons in multiple sclerosis. Proc Natl Acad Sci U S A 2019;116:15216–15225.
18. Ariza ME, Williams MV. A human endogenous retrovirus K dUTPase triggers a TH1, TH17 cytokine response: does it have a role in psoriasis? J Invest Dermatol 2011;131:2419–2427.
19. Reynier F, Verjat T, Turrel F, Imbert PE, Marotte H, Mougin B,
et al. Increase in human endogenous retrovirus HERV-K (HML-2) viral load in active rheumatoid arthritis. Scand J Immunol 2009;70:295–299.
20. Gao Y, Yu XF, Chen T. Human endogenous retroviruses in cancer: expression, regulation and function. Oncol Lett 2021;21:121.
22. Farrell PJ. Epstein-Barr virus and cancer. Annu Rev Pathol 2019;14:29–53.
25. Zack F, Klingel K, Kandolf R, Wegener R. Sudden cardiac death in a 5-year-old girl associated with parvovirus B19 infection. Forensic Sci Int 2005;155:13–17.
26. Juhasz Z, Tiszlavicz L, Kele B, Terhes G, Deak J, Rudas L,
et al. Sudden cardiac death from parvovirus B19 myocarditis in a young man with Brugada syndrome. J Forensic Leg Med 2014;25:8–13.
28. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N,
et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078–2079.
30. Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS,
et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 2012;19:455–477.
35. Jurka J. Repbase update: a database and an electronic journal of repetitive elements. Trends Genet 2000;16:418–420.
37. Nurk S, Bankevich A, Antipov D, Gurevich A, Korobeynikov A, Lapidus A, et al. Assembling genomes and mini-metagenomes from highly chimeric reads. In: Research in Computational Molecular Biology. RECOMB 2013. Lecture Notes in Computed Science, Vol. 7821 (Deng M, Jiang R, Sun F, Zhang X, eds.). Berlin: Springer, 2013. pp. 158–170.
38. Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck B, Stremlau A,
et al. Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 1985;314:111–114.
39. Lee M, Hills M, Conomos D, Stutz MD, Dagg RA, Lau LM,
et al. Telomere extension by telomerase and ALT generates variant repeats by mechanistically distinct processes. Nucleic Acids Res 2014;42:1733–1746.
40. Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y,
et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 2012;44:765–769.
41. Hudnall SD, Chen T, Allison P, Tyring SK, Heath A. Herpesvirus prevalence and viral load in healthy blood donors by quantitative real-time polymerase chain reaction. Transfusion 2008;48:1180–1187.
44. Xie Y, Xue Q, Jiao W, Wu J, Yu Y, Zhao L,
et al. Associations between sputum torque teno virus load and lung function and disease severity in patients with chronic obstructive pulmonary disease. Front Med (Lausanne) 2021;8:618757.
46. Desingu PA, Nagarajan K, Dhama K. Can a torque teno virus (TTV) be a naked DNA particle without a virion structure? Fron Virol 2022;2:821298.
47. Sawata T, Bando M, Nakayama M, Mato N, Yamasawa H, Takahashi M,
et al. Clinical significance of changes in Torque teno virus DNA titer after chemotherapy in patients with primary lung cancer. Respir Investig 2018;56:173–178.
48. Matsubara H, Michitaka K, Horiike N, Yano M, Akbar SM, Torisu M,
et al. Existence of TT virus DNA in extracellular body fluids from normal healthy Japanese subjects. Intervirology 2000;43:16–19.
53. Chen X, Kost J, Sulovari A, Wong N, Liang WS, Cao J,
et al. A virome-wide clonal integration analysis platform for discovering cancer viral etiology. Genome Res 2019;29:819–830.
54. Wallace AD, Wendt GA, Barcellos LF, de Smith AJ, Walsh KM, Metayer C,
et al. To ERV is human: a phenotype-wide scan linking polymorphic human endogenous retrovirus-K insertions to complex phenotypes. Front Genet 2018;9:298.
56. Garazha A, Ivanova A, Suntsova M, Malakhova G, Roumiantsev S, Zhavoronkov A,
et al. New bioinformatic tool for quick identification of functionally relevant endogenous retroviral inserts in human genome. Cell Cycle 2015;14:1476–1484.
58. Benito B, Sarkozy A, Mont L, Henkens S, Berruezo A, Tamborero D,
et al. Gender differences in clinical manifestations of Brugada syndrome. J Am Coll Cardiol 2008;52:1567–1573.
60. Ohno S, Zankov DP, Ding WG, Itoh H, Makiyama T, Doi T,
et al. KCNE5 (KCNE1L) variants are novel modulators of Brugada syndrome and idiopathic ventricular fibrillation. Circ Arrhythm Electrophysiol 2011;4:352–361.
61. Benito B, Berruezo A. Brugada syndrome and pregnancy: delving into the role of sex hormones in ion channelopathies. Rev Esp Cardiol (Engl Ed) 2014;67:165–167.
62. Yang G, Liu J, Wang Y, Du Y, Ma A, Wang T. Lack of influence of sex hormones on Brugada syndrome-associated mutant Nav1.5 sodium channel. J Electrocardiol 2019;52:82–87.
64. Krasovec T, Sikonja J, Zerjav Tansek M, Debeljak M, Ilovar S, Trebusak Podkrajsek K,
et al. Long-term follow-up of three family members with a novel NNT pathogenic variant causing primary adrenal insufficiency. Genes (Basel) 2022;13:717.
67. Nickel AG, von Hardenberg A, Hohl M, Loffler JR, Kohlhaas M, Becker J,
et al. Reversal of mitochondrial transhydrogenase causes oxidative stress in heart failure. Cell Metab 2015;22:472–484.
69. Vandepoele K, Andries V, Van Roy N, Staes K, Vandesompele J, Laureys G,
et al. A constitutional translocation t(1;17)(p36.2;q11.2) in a neuroblastoma patient disrupts the human NBPF1 and ACCN1 genes. PLoS One 2008;3:e2207.
70. Andries V, Vandepoele K, Van Roy F. The NBPF gene family. In: Neuroblastoma: Present and Future (Shimada H, ed.). Rijeka: InTech, 2012. pp. 185–214.
71. Kumarswamy R, Bauters C, Volkmann I, Maury F, Fetisch J, Holzmann A,
et al. Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure. Circ Res 2014;114:1569–1575.
72. Liao J, He Q, Li M, Chen Y, Liu Y, Wang J. LncRNA MIAT: myocardial infarction associated and more. Gene 2016;578:158–161.
73. Zhu L, Li N, Sun L, Zheng D, Shao G. Non-coding RNAs: the key detectors and regulators in cardiovascular disease. Genomics 2021;113:1233–1246.
74. Wang Y, Hu Y, Wu G, Yang Y, Tang Y, Zhang W,
et al. Long noncoding RNA PCAT-14 induces proliferation and invasion by hepatocellular carcinoma cells by inducing methylation of miR-372. Oncotarget 2017;8:34429–34441.
76. Kullo IJ, Shameer K, Jouni H, Lesnick TG, Pathak J, Chute CG,
et al. The ATXN2-SH2B3 locus is associated with peripheral arterial disease: an electronic medical record-based genome-wide association study. Front Genet 2014;5:166.
77. Shukla S, Zhang X, Niknafs YS, Xiao L, Mehra R, Cieslik M,
et al. Identification and validation of PCAT14 as prognostic biomarker in prostate cancer. Neoplasia 2016;18:489–499.